The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Verve Therapeutics(NASDAQ:VERV) 
Verve Therapeutics, Inc, a clinical stage genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases in the United States.
Share this website to your friends
Verve Therapeutics Days Payable Outstanding ttm (DPO)
Verve Therapeutics Days Receivable Outstanding ttm (DSO)
Verve Therapeutics Op Cashflow Per Share ttm
Verve Therapeutics Free Cashflow Per Share ttm
Verve Therapeutics Cash Per Share ttm
Verve Therapeutics P/S ratio ttm
Verve Therapeutics (GAAP) P/E ratio ttm
Verve Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.